Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients

Endocrinol Metab Clin North Am. 2018 Mar;47(1):237-257. doi: 10.1016/j.ecl.2017.10.006. Epub 2017 Dec 18.

Abstract

We discuss mechanisms of increased cardiovascular disease (CVD) in patients with chronic kidney disease (CKD) and strategies for managing cardiovascular (CV) risk in these patients. Our focus was mainly on decreasing CV events and progression of microvascular complications by reducing levels of glucose and lipids. We searched PubMed with no limit on the date of the article. All articles were discussed among all authors. We chose pertinent articles, and searched their references in turn for additional relevant publications.

Keywords: A1C; Cardiovascular risk factors; Chronic kidney disease; Diabetes mellitus; Dyslipidemia of chronic kidney disease; Fructosamine; Glycated albumin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticholesteremic Agents / pharmacology*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / etiology
  • Diabetes Complications / drug therapy*
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / etiology
  • Humans
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / drug therapy*
  • Renal Insufficiency, Chronic / etiology

Substances

  • Anticholesteremic Agents